← Medication & Supplement Reference

VETERINARY TEAM REFERENCE · MEDICATION

Pentosan polysulfate sodium

Updated October 27, 2026 · Sources and review status below

For veterinarians and veterinary staff. Product-label information is distinct from extra-label clinical practice. This is not a complete prescribing formulary or an automated interaction screen. Verify the current label, exact formulation, patient and species-specific clinical reference before use. Independent veterinary/pharmacy review remains pending.

Prescribing overview

Controls clinical signs associated with equine osteoarthritis.

Heparin-like polysulfated xylanProduct-specific clinical reference

FDA-approved injectable pentosan; approval does not establish equivalence to compounded pentosan or human oral products.

Key prescribing checks

  • Review the full product-specific safety section and the patient’s complete treatment plan.

Uses by species

Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.

Horses

US veterinary product label

Clinical signs of osteoarthritis

Patient and indication restrictions apply.

Use / indication source ↗

Pharmacology & pharmacokinetics

Mechanism and clinical role

Has anticoagulant activity; the joint mechanism is incompletely understood.

Absorption, distribution, metabolism and elimination

Quantitative equine kinetics were not established in this label review.

SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC

Contraindications & cautions

Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.

Zycosan

US Intramuscular injection for horses label.

Contraindications · when not to use

  • Avoid hypersensitivity, anticoagulants, clotting disorders and use within 24 hours of surgery.

Precautions & monitoring

  • May worsen exercise-induced pulmonary hemorrhage. Reproductive and long-term repeat-use safety are unestablished.

Selected safety information; not a complete interaction assessment.

Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.

Adverse effects

Injection-site reactions, prolonged clotting times, lethargy, behavioral changes and colic occur.

These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.

Dosing & administration

Verify the source before prescribing. The regimens below summarize selected veterinary product labels, not every accepted veterinary use. They are not automatic substitutions between brands or formulations. Renal/hepatic disease, concurrent therapy, age, indication and clinical response can require a different plan.

A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.

Select a regimen from the current exact-product label with the prescribing veterinarian; no calculator regimen is supplied for this entry.

Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗

Drug & supplement interactions

This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.

Compare with other medications and check species →

Zycosan

US Intramuscular injection for horses label.

  • NSAID coadministration needs bleeding surveillance; it is not the same prohibition as anticoagulant use.
Interaction source ↗Interaction source ↗

Monitoring

Assess bleeding, injection reactions and mobility response.

Client counseling

Not for food-chain horses. Report nosebleeds, bruising or colic.

This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.

Storage & handling

Room-temperature storage; single-use preservative-free vial, discard remainder.

Brands, formulations & ingredient identity

Active ingredients

Pentosan polysulfate sodium

Other searchable names: Zycosan · Sodium pentosan polysulfate

This reference covers the named US product and route; other formulations need separate verification.

Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.

Zycosan

Formulation
Intramuscular injection for horses
Label / product scope
Horses

US labeled presentation; verify the current package.

Product label / source ↗

References & review status

Clinical reference updated October 27, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.

Search another medication or supplement →

CONTINUE EXPLORING

Use these connected guides to prepare informed questions for your veterinary team.

Find Veterinary Care Near YouLocate general practices, urgent-care clinics, emergency hospitals and specialists.Read resource →When It Is an EmergencyRecognize signs that require immediate veterinary care.Read resource →Interactive Symptom NavigatorStart with what you notice and understand when to seek help.Read resource →Poisons and Household HazardsRecognize common exposures and avoid unsafe home treatment.Read resource →Printable Owner ToolkitBring observations, medication details and questions to your appointment.Read resource →
Privacy & cookie choices